| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 28 Jan 25 | CRIS Curis | Non Qualified Stock Option Common Stock | Grant | Acquire A | No | No | 3.13 | 1,600 | 5.01 k | 1,600 |
| 23 Jan 25 | GALT Galectin Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 1.23 | 60,000 | 73.80 k | 60,000 |
| 21 May 24 | CRIS Curis | Non Qualified Stock Option Common Stock | Grant | Acquire A | No | No | 11.62 | 4,250 | 49.39 k | 4,250 |
| 24 Jan 24 | GALT Galectin Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 1.72 | 50,000 | 86.00 k | 50,000 |
